This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Saturday, March 25 • 3:20pm - 4:05pm
Co-Chair Multidisciplinary Panel Clinical Trial vs. Real World: Therapeutic Approaches to Immune-Mediated Inflammatory Disease

Sign up or log in to save this to your schedule and see who's attending!

Efficacy is the measurement of treatment benefit under ideal conditions, such as controlled clinical trial. Effectiveness is the measurement of treatment benefit under real world conditions. Safety is a critical issue and challenge to all prescribers of biologics particularly for events shared across diseases and drugs. Three of the nation’s leading IMID experts will share their experiences and expertise to discuss the effectiveness of treatment post-approval and implications for their respective specialties.

  • Identify differences between and methods to optimize efficacy and effectiveness as demonstrated in clinical trials vs real world settings
  • Critically appraise the issue of HBV reactivation as a safety issue shared across IMIDS and specialties to examine lessons learned 
  • Compare IMID treatment algorithms in clinical practice between rheumatology, dermatology, and gastroenterology

avatar for Leonard H. Calabrese, DO

Leonard H. Calabrese, DO

Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University R.J. Fasenmyer Chair of Clinical Immunology Theodore F. Classen, DO Chair of Osteopathic Research and Education Vice Chairman, Department of Rheumatic and Immunologic Diseases
avatar for Stephen B. Hanauer, MD

Stephen B. Hanauer, MD

Clifford Joseph Barborka Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Digestive Health Center
Stephen B. Hanauer is past President of the American College of Gastroenterology.  He completed a medical degree, with honors, at the University of Illinois in Chicago. His postdoctoral training included an internship and residency in internal medicine, as well as a fellowship in gastroenterology, at the University of Chicago.  He rose through academic ranks to become Professor of Medicine and subsequently was awarded the Joseph B... Read More →
avatar for Joel M. Gelfand, MD, MSCE

Joel M. Gelfand, MD, MSCE

Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit; Director, Psoriasis and Phototherapy Treatment Center; Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Professor of Dermatology, Professor of Epidemiology
Dr. Gelfand is Associate Professor of Dermatology and Epidemiology at the University of Pennsylvania’s Perelman School of Medicine. He is principal investigator of three large National Institutes of Health funded psoriasis projects: The Dermatology Clinical Effectiveness Research Network (DCERN) which evaluates the effectiveness of psoriasis treatments under real world conditions, the Incident Health Outcomes and Psoriasis Events (iHOPE... Read More →

Saturday March 25, 2017 3:20pm - 4:05pm